Inactive Instrument

Other languages Horizon Pharma Inc Nasdaq

Equities

US44047T1097

End-of-day quote Nasdaq Other stock markets
- ^USD	-

Jan. 16	Health Canada Approves Horizon Therapeutics plc 's UPLIZNA® (inebilizumab for injection) for the Treatment of Neuromyelitis Optica Spectrum Disorders	CI
2023	Global markets live: Boeing, Amgen, Microsoft, Volkswagen, Tesla...

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Health Canada Approves Horizon Therapeutics plc 's UPLIZNA® (inebilizumab for injection) for the Treatment of Neuromyelitis Optica Spectrum Disorders	Jan. 16
Amgen : en hausse, un analyste relève son objectif	23-10-12
Le Proche-Orient, nouvelle inconnue dans l'équation	23-10-09
En Direct des Marchés : TotalEnergies, Airbus, Virbac, Marie Brizard, Mirati, Metro Bank, Vitesco, Disney...	23-10-09
EN DIRECTO DESDE LOS MERCADOS: Microsoft, Airbus, BMW, HSBC, Mirati, Metro Bank, Amgen, Banca Monte Dei Paschi, Vitesco, Disney...	23-10-09
Bolsa de Madrid: Oriente Medio, la nueva incógnita de la ecuación	23-10-09
Wall Street termine en hausse, finalement satisfaite du rapport sur l'emploi	23-10-07
Horizon Therapeutics Public Limited Company Announces the Cessation of Member of the Board of Directors	23-10-06
Amgen a finalisé le rachat d'Horizon pour près de 28 milliards de dollars	23-10-06
Amgen completes $27.8 bln Horizon deal	23-10-06
Amgen Completes Acquisition of Horizon Therapeutics	23-10-06
Les valeurs à suivre aujourd'hui à Wall Street - Vendredi 6 octobre 2023	23-10-06
Amgen : finalise le rachat de Horizon Therapeutics	23-10-06
Amgen completes acquisition of Horizon Therapeutics	23-10-06
Amgen Inc. completed the acquisition of Horizon Therapeutics Public Limited Company.	23-10-05
La fusion Amgen/Horizon validée par la justice irlandaise	23-10-05
Amgen Wins Irish Court Approval to Acquire Horizon Therapeutics	23-10-05
Horizon Therapeutics Public Limited Company Announces New Analysis of Adhering to Uninterrupted Full Course of Treatment with Tepezza to Support Thyroid Eye Disease Patient Outcomes	23-09-29
Nvidia, Amgen back AI-driven drug firm Generate:Biomedicines' $273 mln fundraise	23-09-14
Horizon Therapeutics, Q32 Bio Say First Patient Dosed in Phase 2 Trial of Bempikibart in Severe Alopecia Areata	23-09-13

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Horizon Pharma Inc Nasdaq

Equities

US44047T1097

Other languages

Filters